BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003;332:11-9. [PMID: 12763274 DOI: 10.1016/s0009-8981(03)00129-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48:195-203. [PMID: 24172179 DOI: 10.1097/01.mcg.0000436438.60145.5a] [Cited by in Crossref: 194] [Cited by in F6Publishing: 160] [Article Influence: 27.7] [Reference Citation Analysis]
2 Bargiota A, Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab 2012;3:27-47. [PMID: 23148192 DOI: 10.1177/2042018812437355] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
3 Glueck CJ, Khan N, Riaz M, Padda J, Khan Z, Wang P. Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy. Lipids Health Dis 2012;11:143. [PMID: 23110706 DOI: 10.1186/1476-511X-11-143] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
4 de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management. United European Gastroenterol J 2018;6:649-55. [PMID: 30083325 DOI: 10.1177/2050640618755002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
5 Smellie WS, Forth J, Bareford D, Twomey P, Galloway MJ, Logan EC, Smart SR, Reynolds TM, Waine C. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9. [PMID: 16873560 DOI: 10.1136/jcp.200X.033944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
6 Goldberg RB, Chait A. A Comprehensive Update on the Chylomicronemia Syndrome. Front Endocrinol (Lausanne) 2020;11:593931. [PMID: 33193106 DOI: 10.3389/fendo.2020.593931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Castro-Castro MJ, Candás-Estébanez B, Esteban-Salán M, Calmarza P, Arrobas-Velilla T, Romero-Román C, Pocoví-Mieras M, Aguilar-Doreste JÁ; Commission on Lipoprotein and Vascular Diseases, Sociedad Española de Química Clínica. Removing Lipemia in Serum/Plasma Samples: A Multicenter Study. Ann Lab Med 2018;38:518-23. [PMID: 30027694 DOI: 10.3343/alm.2018.38.6.518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]